Evidence map›Paper›PMID 24788194›Full record

ArticleJournal of genetic counseling2014

Attitudes towards potentially carrying the FMR1 premutation: before vs after testing of non-carrier females with diminished ovarian reserve.

Lisa M Pastore, Maria Antero, Karen Ventura, J Kim Penberthy, Semara A Thomas, Logan B Karns

Abstract read
In one paragraph

Article in Journal of genetic counseling, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Harms of Deception in FMR1 Premutation Genotype-Driven Recruitment.The American journal of bioethics : AJOB · 2017
    Article
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Lisa M PastoreDepartment of Obstetrics and Gynecology, School of Medicine, University of Virginia, Box 800712, Charlottesville, VA, 22908-0712, USA, pastorestudies@gmail.com.
Maria Antero
Karen Ventura
J Kim Penberthy
Semara A Thomas
Logan B Karns

Funding

FMR1 CGG Repeats in Primary Ovarian Insufficiency Women vs. 2 Comparison GroupsR01HD068440 · NICHD · UNIVERSITY OF VIRGINIA · PI TIMKO, MICHAEL PAUL · 2011 to 2013
$984k
Fragile X Premutation Tests: Qualitative Study of Infertile Carriers/PartnersR21HD057485 · NICHD · UNIVERSITY OF VIRGINIA · PI PASTORE, LISA M · 2008 to 2009
$312k
Fragile X Premutations Among Women Diagnosed with Diminished Ovarian ReserveR03HD052768 · NICHD · UNIVERSITY OF VIRGINIA · PI PASTORE, LISA M · 2007 to 2008
$162k
NICHD NIH HHS R01 HD068440NICHD NIH HHS R01HD068440NICHD NIH HHS R03 HD052768NICHD NIH HHS R03HD052768NICHD NIH HHS R21 HD057485NICHD NIH HHS R21HD057485
6 · The paper itself

Abstract

Diminished ovarian reserve (DOR) and premature ovarian failure are associated with elevated FMR1 CGG repeat alleles. We assessed pretest attitudes about potentially carrying the FMR1 premutation (FXP) (>55 CGG repeats) among reproductive age women compared with attitudes after learning their non-carrier status. Ninety-two women with DOR, regular menses and no family history of Fragile X Syndrome underwent FMR1 testing and completed attitudinal questionnaires before (T1) and 3 months after learning the test results (T2). The analysis utilized signed rank tests and α = 0.05. Very few women thought they were likely to have a FXP (6.6%). More participants thought FMR1 premutations were "serious" at T2 (62.9%) than at T1 (46.1%, p < 0.0003). When asked at T1 to "describe your feelings when you consider that you are potentially a carrier" of a FXP, 10% had negative feelings, 50% felt ambivalent, and 40% had positive feelings. At T2, feelings about not being a carrier were significantly more favorable (p < 0.0001): negative (0%), ambivalent (6.5%), positive (93%). Corroborating prior reports, few women had a negative view of FXP, perhaps anticipating that carrying the FXP explains their infertility. Perception of the seriousness of FXP increased after learning they did not carry the FXP, which would be predicted by health belief models.

Indexed as

Attitude to HealthAdultAllelesFemaleFragile X Messenger Ribonucleoprotein 1Fragile X SyndromeHumansOvarian ReservePrimary Ovarian InsufficiencySurveys and QuestionnairesYoung AdultFMR1 protein, humanFragile X Messenger Ribonucleoprotein 1

Identifiers

PMID24788194
PMCPMC5225992

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.